drugset / Trial / NCT06584461

Interest of Lidocaine in Children with Upper Airway Infection Undergoing General Anesthesia

NCT06584461 ↗

Phase 4 Completed 102 enrolled Tunis University
RandomizedParallel-groupDouble-blindPrevention

Summary

The goal of this clinical trial is to determine whether intravenous (IV) lidocaine reduces the incidence of perioperative respiratory complications (PRCs) in children with upper respiratory tract infections undergoing general anesthesia. The study will also evaluate the safety of IV lidocaine in this population. The main questions it aims to answer are: 1. Does IV lidocaine lower the incidence of perioperative respiratory complications (e.g., laryngospasm, cough, desaturation) compared to a placebo? 2. What are the side effects associated with the administration of IV lidocaine in these children? Researchers will compare IV lidocaine to a placebo to assess its effectiveness in reducing PRCs.

Timeline

Start
2023-01-02
Primary completion
2023-12-31
Completion
2024-02-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.5 mg/kg Intravenous